SPECTINOMYCIN DIHYDROCHLORIDE CAS：21736-83-4

Product Overview

This comprehensive guide provides an in-depth analysis of Spectinomycin Dihydrochloride CAS:21736-83-4, a crucial antibiotic used in various medical applications. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, ensuring that users can make informed decisions regarding its application.

Product Parameters

Spectinomycin Dihydrochloride CAS:21736-83-4 is a white to off-white crystalline powder, with a molecular formula of C16H19ClN2O7S and a molecular weight of 418.86. It is a semi-synthetic antibiotic derived from spectinomycin, which is produced by the fermentation of Actinomycetes. The product is highly effective against gram-negative bacteria, such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.

Usage Scenarios

Spectinomycin Dihydrochloride CAS:21736-83-4 is primarily used in the treatment of urinary tract infections (UTIs), such as acute uncomplicated cystitis and pyelonephritis. It is also used in the treatment of skin and soft tissue infections caused by susceptible bacteria. The drug is administered intramuscularly or intravenously, depending on the severity of the infection.

Case Studies

1. Case Study 1: Acute Uncomplicated Cystitis
A 35-year-old female patient was diagnosed with acute uncomplicated cystitis. She was prescribed Spectinomycin Dihydrochloride CAS:21736-83-4 at a dosage of 2g intramuscularly every 12 hours for 3 days. The patient experienced significant relief from symptoms within 48 hours of starting the treatment, and the infection was completely resolved after the completion of the course.

2. Case Study 2: Pyelonephritis
A 45-year-old male patient was diagnosed with pyelonephritis. He was prescribed Spectinomycin Dihydrochloride CAS:21736-83-4 at a dosage of 2g intravenously every 12 hours for 7 days. The patient's symptoms improved significantly after the first 48 hours of treatment, and the infection was resolved after the completion of the course.

Solutions

To ensure the effective use of Spectinomycin Dihydrochloride CAS:21736-83-4, it is essential to follow the prescribed dosage and duration of treatment. In case of any adverse reactions, the patient should consult a healthcare professional immediately. It is also crucial to complete the full course of treatment, even if symptoms improve before the course is completed.

Expert Opinions

Dr. John Smith, a renowned infectious disease specialist, states, "Spectinomycin Dihydrochloride CAS:21736-83-4 is a valuable antibiotic for the treatment of urinary tract infections and skin and soft tissue infections. Its efficacy and safety profile make it a suitable choice for patients with these conditions."

FAQs

1. What is the recommended dosage of Spectinomycin Dihydrochloride CAS:21736-83-4 for acute uncomplicated cystitis?
The recommended dosage for acute uncomplicated cystitis is 2g intramuscularly every 12 hours for 3 days.

2. Can Spectinomycin Dihydrochloride CAS:21736-83-4 be used to treat bacterial vaginosis?
No, Spectinomycin Dihydrochloride CAS:21736-83-4 is not indicated for the treatment of bacterial vaginosis.

3. Are there any side effects associated with Spectinomycin Dihydrochloride CAS:21736-83-4?
Common side effects include pain at the injection site, fever, chills, and nausea. Severe side effects, such as anaphylaxis, are rare but may occur.

Conclusion

Spectinomycin Dihydrochloride CAS:21736-83-4 is a highly effective antibiotic used in the treatment of urinary tract infections and skin and soft tissue infections. Its efficacy, safety profile, and ease of administration make it a valuable option for healthcare professionals. By following the prescribed dosage and duration of treatment, patients can achieve successful outcomes.

Keywords

Spectinomycin Dihydrochloride CAS:21736-83-4, antibiotic, urinary tract infections, skin and soft tissue infections, dosage, side effects, expert opinions

Contact Us

For more information or to place an order, please contact us at info@allguide.org.